NEW YORK (GenomeWeb News) – Bruker reported after the close of the market Wednesday that its revenues in the first quarter were up 8 percent year over year, rising to $423.7 million from $393.4 million in Q1 2013.

The results beat the average Wall Street estimate of $402.0 million. Acquisitions and divestitures were responsible for a net positive effect of roughly 1 percent, while foreign currency effects were negligible in the quarter, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.